CD19 & CD47
Loading...Anti-CD19 & CD47 Products
+ Filter
Loading...- anti-CD19 immunotoxin HD37 (scFv)-PE (AGTO-L047E)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
- Anti-Human CD19 Recombinant Antibody (TAB-108CL) (TAB-108CL)
-
- Derivation: Human
- Species Reactivity: Human
- Type: Antibody
- Application: FC, ADCC, FuncS
- Mouse Anti-CD19 Recombinant Antibody; Fab Fragment (TAB-1611CL-F(E)) (TAB-1611CL-F(E))
-
- Species Reactivity: Human
- Type: Mouse Fab
- Application: Depletion, FuncS
- Mouse Anti-CD19 Recombinant Antibody (TAB-1611CL) (TAB-1611CL)
-
- Species Reactivity: Human
- Type: Mouse IgG2a, κ
- Application: Depletion, FuncS
- Mouse Anti-CD19 Recombinant Antibody (clone HIB19) (NEUT-287CQ)
-
- Species Reactivity: Human, Chimpanzee
- Type: Mouse IgG1, κ
- Application: FC, CyTOF, IHC, Block
- Anti-Human CD19 Recombinant Antibody scFv Fragment (HD37) (TAB-1620CL-S(P))
-
- Application: FuncS
- Human Anti-CD19 Recombinant Antibody Fab Fragment (TAB-1627CL-F(E)) (TAB-1627CL-F(E))
-
- Type: Fully human antibody
- Application: Depletion
- Mouse Anti-CD19 Recombinant Antibody (clone SJ25-C1) (NEUT-286CQ)
-
- Species Reactivity: Human
- Type: Mouse IgG1
- Application: Neut, FC, IHC, IHC-Fr, IP
- Rat Anti-CD19 Recombinant Antibody (clone 1D3) (NEUT-288CQ)
-
- Species Reactivity: Mouse
- Type: Rat IgG2a
- Application: Depletion, Block, FC
- Human Anti-CD19 Recombinant Antibody; Fab Fragment (TAB-1619CL-F(E)) (TAB-1619CL-F(E))
-
- Species Reactivity: Human
- Type: Human Fab
- Application: ELISA, WB
- Anti-Human CD19 Recombinant Antibody (396) (TAB-1625CL)
-
- Derivation: Humanized
- Type: Humanized antibody
- Application: Depletion, ELISA
- Human Anti-CD47 Recombinant Antibody; Fab Fragment (TAB-278LC-F(E)) (TAB-278LC-F(E))
-
- Species Reactivity: Human
- Type: Human Fab
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody (TAB-281LC) (TAB-281LC)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized antibody
- Application: ELISA
- Anti-Human CD19 Recombinant Antibody scFv Fragment (cHD37) (TAB-1621CL-S(P))
-
- Derivation: Chimeric (mouse/human)
- Type: Chimeric antibody (mouse/human)
- Application: FuncS
- Human Anti-CD19 Recombinant Antibody (TAB-1612CL) (TAB-1612CL)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized IgG1
- Application: Depletion, FuncS
- Human Anti-CD19 Recombinant Antibody (TAB-1613CL) (TAB-1613CL)
-
- Derivation: Chimeric (mouse/human)
- Species Reactivity: Human
- Type: Chimeric (mouse/human) IgG1
- Application: Cyt, FC, FuncS, Inhib
- Human Anti-CD19 Recombinant Antibody (TAB-1614CL) (TAB-1614CL)
-
- Derivation: Chimeric (mouse/human)
- Species Reactivity: Human
- Type: Chimeric (mouse/human) IgG
- Application: FuncS
- Human Anti-CD19 Recombinant Antibody (TAB-1616CL) (TAB-1616CL)
-
- Species Reactivity: Human
- Type: Human IgG
- Application: ELISA, WB
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: scFv fragment
- Human Anti-CD19 Recombinant Antibody; scFv Fragment (TAB-1612CL-S(P)) (TAB-1612CL-S(P))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized scFv
- Application: Depletion, FuncS
- Mouse Anti-CD19 Recombinant Antibody; scFv Fragment (TAB-1613CL-S(P)) (TAB-1613CL-S(P))
-
- Derivation: Chimeric (mouse/human)
- Species Reactivity: Human
- Type: Mouse scFv
- Application: Depletion, FuncS
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG2b
- Application: WB, FC, IHC, IP, FuncS
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG1
- Application: WB, FC, ICC, IF, FuncS
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: IgG1 - kappa
- Application: IF, IP, Neut, FuncS, ELISA, FC, WB
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized IgG1, κ
- Application: ELISA, FC, IP, FuncS, IF, Neut, ICC
- Human Anti-CD19 Recombinant Antibody; Fab Fragment (TAB-1612CL-F(E)) (TAB-1612CL-F(E))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized Fab
- Application: Depletion, FuncS
- Human Anti-CD19 Recombinant Antibody; Fab Fragment (TAB-1613CL-F(E)) (TAB-1613CL-F(E))
-
- Derivation: Chimeric (mouse/human)
- Species Reactivity: Human
- Type: Chimeric (mouse/human) Fab
- Application: Depletion, FuncS
- Human Anti-CD19 Recombinant Antibody; Fab Fragment (TAB-1614CL-F(E)) (TAB-1614CL-F(E))
-
- Derivation: Chimeric (mouse/human)
- Species Reactivity: Human
- Type: Chimeric (mouse/human) Fab
- Application: FuncS
- Human Anti-CD19 Recombinant Antibody; Fab Fragment (TAB-1616CL-F(E)) (TAB-1616CL-F(E))
-
- Species Reactivity: Human
- Type: Human Fab
- Application: ELISA, WB
- Human Anti-CD19 Recombinant Antibody; Fab Fragment (TAB-1617CL-F(E)) (TAB-1617CL-F(E))
-
- Species Reactivity: Human
- Type: Human Fab
- Application: ELISA, WB
- Human Anti-CD19 Recombinant Antibody; Fab Fragment (TAB-1618CL-F(E)) (TAB-1618CL-F(E))
-
- Species Reactivity: Human
- Type: Human Fab
- Application: ELISA, WB
- Human Anti-CD19 Recombinant Antibody (TAB-1617CL) (TAB-1617CL)
-
- Species Reactivity: Human
- Type: Human IgG
- Application: ELISA, WB
- Human Anti-CD47 Recombinant Antibody (TAB-278LC) (TAB-278LC)
-
- Species Reactivity: Human
- Type: Human IgG, κ
- Application: Block, FuncS
- Human Anti-CD47 Recombinant Antibody (TAB-279LC) (TAB-279LC)
-
- Species Reactivity: Human
- Type: Human IgG, κ
- Application: Block, FuncS
- Human Anti-CD47 Recombinant Antibody (TAB-280LC) (TAB-280LC)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized antibody
- Application: ELISA
-
- Derivation: Human
- Species Reactivity: Human
- Type: ADCC enhanced antibody
- Mouse Anti-CD19 Recombinant Antibody; scFv Fragment (TAB-1614CL-S(P)) (TAB-1614CL-S(P))
-
- Derivation: Chimeric (mouse/human)
- Species Reactivity: Human
- Type: Mouse scFv
- Application: FuncS
- Human Anti-CD19 Recombinant Antibody; scFv Fragment (TAB-1616CL-S(P)) (TAB-1616CL-S(P))
-
- Species Reactivity: Human
- Type: Human scFv
- Application: ELISA, WB
- Human Anti-CD19 Recombinant Antibody; scFv Fragment (TAB-1617CL-S(P)) (TAB-1617CL-S(P))
-
- Species Reactivity: Human
- Type: Human scFv
- Application: ELISA, WB
- Human Anti-CD19 Recombinant Antibody; scFv Fragment (TAB-1618CL-S(P)) (TAB-1618CL-S(P))
-
- Species Reactivity: Human
- Type: Human scFv
- Application: ELISA, WB
- Human Anti-CD19 Recombinant Antibody; scFv Fragment (TAB-1619CL-S(P)) (TAB-1619CL-S(P))
-
- Species Reactivity: Human
- Type: Human scFv
- Application: ELISA, WB
- Human Anti-CD19 Recombinant Antibody Fab Fragment (TAB-1626CL-F(E)) (TAB-1626CL-F(E))
-
- Type: Fully human antibody
- Application: Depletion
- Anti-Human CD19 Recombinant Antibody scFv Fragment (396) (TAB-1625CL-S(P))
-
- Derivation: Humanized
- Type: Humanized antibody
- Application: Depletion, ELISA
- Human Anti-CD19 Recombinant Antibody scFv Fragment (TAB-1626CL-S(P)) (TAB-1626CL-S(P))
-
- Type: Fully human antibody
- Application: Depletion
- Human Anti-CD19 Recombinant Antibody scFv Fragment (TAB-1627CL-S(P)) (TAB-1627CL-S(P))
-
- Type: Fully human antibody
- Application: Depletion
- Human Anti-CD47 Recombinant Antibody; scFv Fragment (TAB-278LC-S(P)) (TAB-278LC-S(P))
-
- Species Reactivity: Human
- Type: Human scFv
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody; scFv Fragment (TAB-279LC-S(P)) (TAB-279LC-S(P))
-
- Species Reactivity: Human
- Type: Human scFv
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody; scFv Fragment (TAB-280LC-S(P)) (TAB-280LC-S(P))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized scFv
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody; scFv Fragment (TAB-281LC-S(P)) (TAB-281LC-S(P))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized scFv
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody; scFv Fragment (TAB-282LC-S(P)) (TAB-282LC-S(P))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized scFv
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody; scFv Fragment (TAB-283LC-S(P)) (TAB-283LC-S(P))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized scFv
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody; scFv Fragment (TAB-284LC-S(P)) (TAB-284LC-S(P))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized scFv
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody; scFv Fragment (TAB-285LC-S(P)) (TAB-285LC-S(P))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized scFv
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody; scFv Fragment (TAB-286LC-S(P)) (TAB-286LC-S(P))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized scFv
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody; scFv Fragment (TAB-287LC-S(P)) (TAB-287LC-S(P))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized scFv
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody; scFv Fragment (TAB-288LC-S(P)) (TAB-288LC-S(P))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized scFv
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody; Fab Fragment (TAB-283LC-F(E)) (TAB-283LC-F(E))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized Fab
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody; Fab Fragment (TAB-284LC-F(E)) (TAB-284LC-F(E))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized Fab
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody; Fab Fragment (TAB-285LC-F(E)) (TAB-285LC-F(E))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized Fab
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody; Fab Fragment (TAB-286LC-F(E)) (TAB-286LC-F(E))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized Fab
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody; Fab Fragment (TAB-287LC-F(E)) (TAB-287LC-F(E))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized Fab
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody; Fab Fragment (TAB-288LC-F(E)) (TAB-288LC-F(E))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized Fab
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody; Fab Fragment (TAB-289LC-F(E)) (TAB-289LC-F(E))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized Fab
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody; Fab Fragment (TAB-290LC-F(E)) (TAB-290LC-F(E))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized Fab
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody; Fab Fragment (TAB-291LC-F(E)) (TAB-291LC-F(E))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized Fab
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody; Fab Fragment (TAB-292LC-F(E)) (TAB-292LC-F(E))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized Fab
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody; Fab Fragment (TAB-293LC-F(E)) (TAB-293LC-F(E))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized Fab
- Application: ELISA
- Anti-CD19 immunotoxin HD37 (IgG)-PE (AGTO-G076E)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
- Anti-CD19 immunotoxin HD37 (IgG)-DT (AGTO-G076D)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
- Anti-CD19 immunotoxin HD37 (IgG)-RTA (AGTO-G076R)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG1, κ
- Application: ELISA, IP, FC, FuncS, Neut, IF, ICC
- anti-CD19 immunotoxin HD37 (scFv)-Sap (AGTO-L047S)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
- anti-CD19 immunotoxin HD37 (scFv)-PAP (AGTO-L047P)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
- Anti-CD19 immunotoxin HD37 (IgG)-Sap (AGTO-G076S)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
- anti-CD19 immunotoxin HD37 (scFv)-DT (AGTO-L047D)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
- Anti-CD19 immunotoxin HD37 (IgG)-PAP (AGTO-G076P)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
- anti-CD19 immunotoxin HD37 (scFv)-RTA (AGTO-L047R)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
- Mouse Anti-CD19 Recombinant Antibody; scFv Fragment (TAB-1611CL-S(P)) (TAB-1611CL-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: Depletion, FuncS
- Anti-Human CD19 Recombinant Antibody (381) (TAB-1624CL)
-
- Application: FC, Inhib, ELISA
- Mouse Anti-CD19 Recombinant Antibody (TAB-1623CL) (TAB-1623CL)
-
- Species Reactivity: Human
- Type: Mouse IgG
- Application: ELISA, FC
- Mouse Anti-CD19 Recombinant Antibody (TAB-1622CL) (TAB-1622CL)
-
- Species Reactivity: Human
- Type: Mouse IgG
- Application: ELISA, FC, Apop, ADCC, FuncS
- Mouse Anti-CD19 Recombinant Antibody; scFv Fragment (TAB-1622CL-S(P)) (TAB-1622CL-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: ELISA, FC, Apop, ADCC, FuncS
- Mouse Anti-CD19 Recombinant Antibody; scFv Fragment (TAB-1623CL-S(P)) (TAB-1623CL-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: ELISA, FC
- Anti-Human CD19 Recombinant Antibody scFv Fragment (381) (TAB-1624CL-S(P))
-
- Application: FC, Inhib, ELISA
- Anti-CD19 (clone huB4)-mc-MMAF ADC (ADC-045LZY)
-
- Target: CD19
- Linker: mc (maleimidocaproyl)
- Drug: MMAF (monomethyl auristatin F)
- Anti-CD19 (clone B496)-SPP-DM1 ADC (ADC-181LZY)
-
- Target: CD19
- Linker: SPP (N-succinimidyl-4-(2-pyridyldithio)pentanoate)
- Drug: DM1(N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine)
- Anti-CD19 (Denintuzumab)-Mc-MMAF ADC (ADC-175LCT)
-
- Target: CD19
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-CD19 (clone B496)-MCC-DM1 ADC (ADC-182LZY)
-
- Target: CD19
- Linker: MCC (Maleimidomethyl cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine)
- Anti-CD19 (clone B496)-mc-vc-PABC-MMAE ADC (ADC-183LZY)
-
- Target: CD19
- Linker: mc-VC-PABC (maleimidocaproyl valine-citrulline-p-aminobenzyl carbamoyl)
- Drug: MMAE (monomethyl auristatin E)
- Anti-CD19 (clone B496)-mc-MMAF ADC (ADC-184LZY)
-
- Target: CD19
- Linker: mc (maleimidocaproyl)
- Drug: MMAF (monomethyl auristatin F)
- Anti-CD19 (clone huB4)-SMCC-DM1 ADC (ADC-157LZY)
-
- Target: CD19
- Linker: SMCC (4-[N-maleimidomethyl] cyclohexane-1 carboxylhydrazide).
- Drug: DM1(N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine)
- Anti-CD19 (clone MDX1435)-vc-duocarmycin ADC (ADC-163LZY)
-
- Target: CD19
- Linker: VC (valine-citrulline)
- Drug: duocarmycin
-
- Target: CD19
- Linker: mc-vc (maleimidocaproyl-valine-alanine)
- Drug: pyrrolobenzodiazepine (PBD) dimers SGD-1882
- Anti-CD19 (hBU12)-Mc-MMAF ADC (SGN-19A) (ADC-L034)
-
- Target: CD19
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
-
- Targets: CD19 & CD47
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
- Anti-CD19 (clone hBU12)-vcPAB-MMAE ADC (ADC-150CL)
-
- Target: CD19
- Linker: VC-PAB (valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)
- Anti-CD19 (hBU12)-mcMMAF ADC (ADC-017LCT)
-
- Target: CD19
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-CD19 (clone BU12)-MC-MMAF ADC (ADC-189CL)
-
- Target: CD19
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-CD19 (hBU12)-Mc-MMAE ADC (ADC-019LCT)
-
- Target: CD19
- Linker: Mc (maleimidocaproyl)
- Drug: MMAE (Monomethyl auristatin E)
- Anti-CD19 (huB4)-SPDB-DM4 ADC (ADC-020LCT)
-
- Target: CD19
- Linker: SPDB (N-succinimidyl 4-(2-pyridyldithio)butyrate)
- Drug: DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine)
View More Products
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
More Infomation
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
Background
CD19: Encodes a B-cell surface receptor involved in antigen signaling. It amplifies B-cell receptor signals to regulate proliferation and differentiation. The protein is essential for humoral immunity. Mutations cause immunodeficiency.
CD47 (CD47 Molecule) is a Protein Coding gene. Diseases associated with CD47 include Hereditary Spherocytosis and Neonatal Meningitis. Among its related pathways are Response to elevated platelet cytosolic Ca2+ and Innate Immune System. Gene Ontology (GO) annotations related to this gene include thrombospondin receptor activity.


Primary Immunodeficiency